Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease: A diagnostic challenge

Nicola S. Gray

doi:10.1002/hup.578

Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease: A diagnostic challenge

Nicola S. Gray

Department of Psychiatry and Behavioral Health

Research output: Contribution to journal › Article › peer-review

27 Scopus citations

Abstract

A case of neuroleptic malignant syndrome (NMS) in a patient with Parkinson's disease (PD) is presented. The syndrome was precipitated by the atypical antipsychotic, ziprasidone. The challenge of recognizing NMS in a patient with underlying parkinsonian symptoms, where prominent symptom overlap can occur, is discussed.

Original language	English (US)
Pages (from-to)	205-207
Number of pages	3
Journal	Human Psychopharmacology
Volume	19
Issue number	3
DOIs	https://doi.org/10.1002/hup.578
State	Published - Apr 2004

All Science Journal Classification (ASJC) codes

Neurology
Clinical Neurology
Psychiatry and Mental health
Pharmacology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/hup.578

Cite this

@article{03b375fe577d4fdba5be3751176a3353,

title = "Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease: A diagnostic challenge",

abstract = "A case of neuroleptic malignant syndrome (NMS) in a patient with Parkinson's disease (PD) is presented. The syndrome was precipitated by the atypical antipsychotic, ziprasidone. The challenge of recognizing NMS in a patient with underlying parkinsonian symptoms, where prominent symptom overlap can occur, is discussed.",

author = "Gray, \{Nicola S.\}",

year = "2004",

month = apr,

doi = "10.1002/hup.578",

language = "English (US)",

volume = "19",

pages = "205--207",

journal = "Human Psychopharmacology",

issn = "0885-6222",

publisher = "John Wiley and Sons Ltd",

number = "3",

}

TY - JOUR

T1 - Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease

T2 - A diagnostic challenge

AU - Gray, Nicola S.

PY - 2004/4

Y1 - 2004/4

N2 - A case of neuroleptic malignant syndrome (NMS) in a patient with Parkinson's disease (PD) is presented. The syndrome was precipitated by the atypical antipsychotic, ziprasidone. The challenge of recognizing NMS in a patient with underlying parkinsonian symptoms, where prominent symptom overlap can occur, is discussed.

AB - A case of neuroleptic malignant syndrome (NMS) in a patient with Parkinson's disease (PD) is presented. The syndrome was precipitated by the atypical antipsychotic, ziprasidone. The challenge of recognizing NMS in a patient with underlying parkinsonian symptoms, where prominent symptom overlap can occur, is discussed.

UR - https://www.scopus.com/pages/publications/1942488288

UR - https://www.scopus.com/pages/publications/1942488288#tab=citedBy

U2 - 10.1002/hup.578

DO - 10.1002/hup.578

M3 - Article

C2 - 15079855

AN - SCOPUS:1942488288

SN - 0885-6222

VL - 19

SP - 205

EP - 207

JO - Human Psychopharmacology

JF - Human Psychopharmacology

IS - 3

ER -

Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease: A diagnostic challenge

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this